Sai Pharma Distributors Profile
Key Indicators
- Authorised Capital ₹ 1.50 Cr
as on 16-11-2024
- Paid Up Capital ₹ 9.90 M
as on 16-11-2024
- Company Age 24 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 8.42 Cr
as on 16-11-2024
- Satisfied Charges ₹ 1.70 Cr
as on 16-11-2024
- Revenue 42.69%
(FY 2023)
- Profit 82.95%
(FY 2023)
- Ebitda 87.73%
(FY 2023)
- Net Worth 59.00%
(FY 2023)
- Total Assets 47.54%
(FY 2023)
About Sai Pharma Distributors
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 Cr and a paid-up capital of Rs 9.90 M.
The company currently has active open charges totaling ₹8.42 Cr. The company has closed loans amounting to ₹1.70 Cr, as per Ministry of Corporate Affairs (MCA) records.
Arun Gudala, Amarnath Gudala, Krishna Gudala, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24239TG2000PTC034017
- Company No.
034017
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Mar 2000
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Sai Pharma Distributors?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Arun Gudala  | Director | 11-Aug-2012 | Current |
| Amarnath Gudala | Director | 01-Feb-2008 | Current |
| Krishna Gudala | Whole-Time Director | 24-Mar-2000 | Current |
| Sampath Gudala | Whole-Time Director | 24-Mar-2000 | Current |
| Renuka Gudala | Whole-Time Director | 24-Mar-2000 | Current |
Financial Performance of Sai Pharma Distributors.
Sai Pharma Distributors Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 42.69% increase. The company also saw a substantial improvement in profitability, with a 82.95% increase in profit. The company's net worth Soared by an impressive increase of 59%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sai Pharma Distributors?
In 2023, Sai Pharma Distributors had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Glivita Pharma Private LimitedActive 6 years 11 monthsArun Gudala, Amarnath Gudala and 3 more are mutual person
- Meds N More Healthcare Private LimitedActive 3 years 9 months
Arun Gudala and Krishna Gudala are mutual person
- Spd Vaccines And Speciality Drugs Private LimitedActive 4 years 9 months
Krishna Gudala and Sampath Gudala are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 09 May 2019 | ₹7.44 Cr | Open |
Others Creation Date: 21 Dec 2018 | ₹7.50 M | Open |
Corporation Bank Creation Date: 08 Oct 2004 | ₹2.30 M | Open |
How Many Employees Work at Sai Pharma Distributors?
Sai Pharma Distributors has a workforce of 50 employees as of Apr 10, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sai Pharma Distributors, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sai Pharma Distributors's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
